| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 59220 | [[5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-3, 4-dihydroxyoxolan-2-yl]methoxy-ydroxyphosphoryl] [3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate, disodium salt | 0.0181211508101519 | 0.36206172 |
| NSC 610458 | Camptothecin Derivative | 0.0181211508101519 | 0.67428242 |
| NSC 627748 | Null | 0.0181211508101519 | 0.20837997 |
| NSC 638441 | Null | 0.0181211508101519 | 0.44832376 |
| NSC 653860 | Null | 0.0181211508101519 | 0.64327301 |
| NSC 659948 | 7-O-(2,3,6-Trideoxy-2-fluoro-.alpha.-L-talo-hexopyranosyl)-4-demethoxydaunomycinone | 0.0181211508101519 | 0.71955465 |
| NSC 681639 | Camptothecin Derivative | 0.0181211508101519 | 0.63030763 |
| NSC 683661 | Acetic acid, amino-, 9-[[(amino)carbonyl]oxy]-13-(2-amino- 1-oxoethoxy)-8,14-dimethoxy-4,10,12,16-tetramethyl- 3,20,22-trioxo-19-[(2-propenyl)amino]-2-azabicyclo [16.3.1]docosa-1(21),4,6,10,18-pentae | 0.0181211508101519 | -0.027977279 |
| NSC 685005 | Null | 0.0181211508101519 | -0.092910181 |
| NSC 686550 | Butanamide, N-(3-chloro-1,4-dioxo-2-naphthalenyl)- N-(1-oxobutyl)- | 0.0181211508101519 | 0.069897816 |